{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T01:30:52Z","timestamp":1763429452295,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00492","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T23:59:28Z","timestamp":1500508768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia"],"prefix":"10.3389","volume":"8","author":[{"given":"Junjing","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soren","family":"Mellemkjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mds.22385","article-title":"Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.","volume":"24","author":"Andersohn","year":"2009","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.athoracsur.2009.04.012","article-title":"Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis.","volume":"88","author":"Brown","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1445-5994.2009.01920.x","article-title":"Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.","volume":"39","author":"Cawood","year":"2009","journal-title":"Intern. Med. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00059-013-3816-0","article-title":"Cabergoline use and risk of fibrosis and insufficiency of cardiac valves. Meta-analysis of observational studies.","volume":"38","author":"De Vecchis","year":"2013","journal-title":"Herz"},{"key":"B5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thx.54.2.161","article-title":"Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.","volume":"54","author":"Egermayer","year":"1999","journal-title":"Thorax"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EJE-12-0121","article-title":"Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.","volume":"167","author":"Elenkova","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1056\/NEJM196602172740701","article-title":"Fibrotic disorders associated with methysergide therapy for headache.","volume":"274","author":"Graham","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.arbres.2008.01.003","article-title":"Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline.","volume":"45","author":"Haro-Estarriol","year":"2009","journal-title":"Arch. Bronconeumol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.athoracsur.2006.09.034","article-title":"Successful steroid treatment for fibrosing mediastinitis and sclerosing cervicitis.","volume":"83","author":"Ikeda","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"B11","first-page":"797","article-title":"Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.","volume":"19","author":"Izgi","year":"2010","journal-title":"J. Heart Valve Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0003-4975(03)00828-2","article-title":"Pulmonary endarterectomy: experience and lessons learned in 1,500 cases.","volume":"76","author":"Jamieson","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/438403","article-title":"5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure.","volume":"2015","author":"Janssen","year":"2015","journal-title":"Biomed Res. Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/01.smj.0000168656.75306.24","article-title":"Complete resolution of fibrosing mediastinitis with corticosteroid therapy.","volume":"98","author":"Lal","year":"2005","journal-title":"South Med. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/EJE-07-0584","article-title":"A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.","volume":"158","author":"Londahl","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-60761-500-2_20","article-title":"The serotonin hypothesis of pulmonary hypertension revisited.","volume":"661","author":"MacLean","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/modpathol.3880373","article-title":"Analysis of MUM1\/IRF4 protein expression using tissue microarrays and immunohistochemistry.","volume":"14","author":"Natkunam","year":"2001","journal-title":"Mod. Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/jpet.102.039883","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12016-016-8584-1","article-title":"Idiopathic mediastinal fibrosis: a systemic immune-mediated disorder. A case series and a review of the literature.","volume":"52","author":"Rossi","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation.","volume":"356","author":"Schade","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.lpm.2013.07.005","article-title":"Drugs induced pulmonary arterial hypertension.","volume":"42","author":"Seferian","year":"2013","journal-title":"Presse Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001800","article-title":"Pulmonary hypertension complicating fibrosing mediastinitis.","volume":"94","author":"Seferian","year":"2015","journal-title":"Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1378\/chest.106.2.484","article-title":"The radiographic findings of fibrosing mediastinitis.","volume":"106","author":"Sherrick","year":"1994","journal-title":"Chest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000209508","article-title":"Treatment of mediastinal fibrosis with mycophenolate mofetil.","volume":"78","author":"Witschi","year":"2009","journal-title":"Respiration"},{"key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.rti.0000213589.29472.18","article-title":"Computed tomography and the idiopathic form of proliferative fibrosing mediastinitis.","volume":"22","author":"Worrell","year":"2007","journal-title":"J. Thorac. Imaging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease.","volume":"356","author":"Zanettini","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00492\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T23:59:31Z","timestamp":1500508771000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00492\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":26,"alternative-id":["10.3389\/fphar.2017.00492"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00492","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2017,7,20]]},"article-number":"492"}}